Diagnosis of Men-I Syndrome on ⁶⁸Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With ¹⁷⁷Lu-DOTATATE

Abstract

Abstract: MEN-I is a rare genetic disorder classically characterized by a predisposition to tumors of the parathyroid glands, anterior pituitary gland, and pancreatic islet cells. We present a case of MEN-I syndrome diagnosed using predominantly nuclear medicine imaging followed by radionuclide therapy, thus emphasizing the role of nuclear imaging in diagnosing and treating MEN-I.